Company intelligence / Profile preview
CHEPLAPHARM
Greifswald/Mesekenhagen/Neuenkirchen area*, Mecklenburg-Western Pomerania, Germanycheplapharm.com ↗
- Ownership
- Private
- Employees
- ~666
- Development stage
- Commercial
01
Overview
CHEPLAPHARM operates as a global specialty pharmaceutical company focused on acquiring well-established branded medicines from major research-based pharma companies. The company ensures continued patient access to these medicines worldwide. It has demonstrated consistent double-digit growth since at least the early 2000s and reported record revenues of €1.5 billion in FY2023 driven by major acquisitions such as the Zyprexa® portfolio from Eli Lilly[6]. Its business model centers on commercializing mature products rather than developing new drugs or clinical-stage assets.
- Therapeutic areas
- GastroenterologyCardiovascularOncologyNeurologyInfectious Diseases
- Modalities
- Primarily small molecules and established branded pharmaceuticals
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Acquisitions/divestments from major pharma companies including AstraZeneca, Roche/F. Hoffmann-La Roche, Bristol Myers Squibb, Sanofi, Eli Lilly & Co., Teva Pharmaceuticals.
Beyond the preview
Go deeper on CHEPLAPHARM.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CHEPLAPHARM.